Stephen R Wisniewski

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Are you Stephen R Wisniewski?

Claim your profile

Publications (441)2416.24 Total impact

  • Lee Baer · Madhukar H. Trivedi · Ilana Huz · A. John Rush · Stephen R. Wisniewski · Maurizio Fava
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Obsessive-compulsive symptoms (OCS) may be underrecognized in patients suffering from major depressive disorder. These patients may not receive optimal psychopharmacologic or psychological treatment if their OCS are not attended to. We performed a secondary analysis of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial database, the largest effectiveness study of "real-world" depression ever conducted, to determine the frequency of OCS and their effects on depression outcome. Method: 3,984 adult subjects without a previous selective serotonin reuptake inhibitor trial for their current major depressive episode, per DSM-IV diagnostic criteria, had data for rating scales of interest at entry into Level 1 of the STAR*D trial, a 12-week open trial of citalopram at a dose of 20-60 mg/d to assess rates of depression remission. Our primary interest was the OCD subscale of the Psychiatric Diagnostic Screening Questionnaire. Results: At study entry, 53% of the STAR*D sample (which excluded patients with primary obsessive-compulsive disorder) endorsed ≥ 1 OCS, and 14% endorsed ≥ 4 OCS. Subjects endorsing ≥ 4 OCS had significantly lower corrected odds of depression remission on both the 17-item Hamilton Depression Rating Scale (HDRS-17) (OR = 0.61) and the Quick Inventory of Depressive Symptomatology (odds ratio [OR] = 0.51). Number of OCS endorsed was positively correlated with HDRS-17 score (r = 0.26, P < .0001). Consistent with findings from the Dunedin, New Zealand Community Study, the most common obsessions were doubts of having inadvertently caused harm and violent obsessions. Conclusions: OCS are common in depressed outpatients and are often not attended to. They impact clinical recovery from depression and should be screened for since sufferers are often reluctant to disclose these symptoms. Trial registration: ClinicalTrials.gov identifier: NCT00021528.
    No preview · Article · Dec 2015 · The Journal of Clinical Psychiatry
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Traumatic brain injury (TBI) is an important worldwide cause of death and disability for children. The Approaches and Decisions for Acute Pediatric TBI (ADAPT) Trial is an observational, cohort study to compare the effectiveness of six aspects of TBI care. Understanding the differences between clinical sites-including their structure, clinical processes, and culture differences-will be necessary to assess differences in outcome from the study and can inform the overall community regarding differences across academic centers. Methods: We developed a survey and queried ADAPT site principal investigators with a focus on six domains: (i) hospital, (ii) pediatric intensive care unit (PICU), (iii) medical staff characteristics, (iv) quality of care, (v) medication safety, and (vi) safety culture. Summary statistics were used to describe differences between centers. Results: ADAPT clinical sites that enrolled a subject within the first year (32 US-based, 11 international) were studied. A wide variation in site characteristics was observed in hospital and ICU characteristics, including an almost sevenfold range in ICU size (8-55 beds) and more than fivefold range of overall ICU admissions (537-2623). Nursing staffing (predominantly 1:1 or 1:2) and the presence of pharmacists within the ICU (79 %) were less variable, and most sites "strongly agreed" or "agreed" that Neurosurgery and Critical Care teams worked well together (81.4 %). However, a minority of sites (46 %) used an explicit protocol for treatment of children with severe TBI care. Conclusions: We found a variety of inter-center structure, process, and culture differences. These intrinsic differences between sites may begin to explain why interventional studies have failed to prove efficacy of experimental therapies. Understanding these differences may be an important factor in analyzing future ADAPT trial results and in determining best practices for pediatric severe TBI.
    No preview · Article · Dec 2015 · Neurocritical Care
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVES:: To describe acute cerebral hemodynamic effects of medications commonly used to treat intracranial hypertension in children with traumatic brain injury. Currently, data supporting the efficacy of these medications are insufficient. DESIGN:: In this prospective observational study, intracranial hypertension (intracranial pressure ≥ 20 mm Hg for > 5 min) was treated by clinical protocol. Administration times of medications for intracranial hypertension (fentanyl, 3% hypertonic saline, mannitol, and pentobarbital) were prospectively recorded and synchronized with an automated database that collected intracranial pressure and cerebral perfusion pressure every 5 seconds. Intracranial pressure crises confounded by external stimulation or mechanical ventilator adjustments were excluded. Mean intracranial pressure and cerebral perfusion pressure from epochs following drug administration were compared with baseline values using Kruskal-Wallis analysis of variance and Dunn test. Frailty modeling was used to analyze the time to intracranial pressure crisis resolution. Mixed-effect models compared intracranial pressure and cerebral perfusion pressure 5 minutes after the medication versus baseline and rates of treatment failure. SETTING:: A tertiary care children’s hospital. PATIENTS:: Children with severe traumatic brain injury (Glasgow Coma Scale score ≤ 8). INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: We analyzed 196 doses of fentanyl, hypertonic saline, mannitol, and pentobarbital administered to 16 children (median: 12 doses per patient). Overall, intracranial pressure significantly decreased following the administration of fentanyl, hypertonic saline, and pentobarbital. After controlling for administration of multiple medications, intracranial pressure was decreased following hypertonic saline and pentobarbital administration; cerebral perfusion pressure was decreased following fentanyl and was increased following hypertonic saline administration. After adjusting for significant covariates (including age, Glasgow Coma Scale score, and intracranial pressure), hypertonic saline was associated with a two-fold faster resolution of intracranial hypertension than either fentanyl or pentobarbital. Fentanyl was significantly associated with the most frequent treatment failure. CONCLUSIONS:: Intracranial pressure decreased after multiple drug administrations, but hypertonic saline may warrant consideration as the first-line drug for treating intracranial hypertension, as it was associated with the most favorable cerebral hemodynamics and fastest resolution of intracranial hypertension. ©2015The Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
    No preview · Article · Dec 2015 · Pediatric Critical Care Medicine
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Functional assessment may represent a valuable addition to postpartum depression screening, providing a more thorough characterization of the mother's health and quality of life. To the authors' knowledge, this analysis represents the first examination of postpartum maternal functioning, as measured by a patient-centered validated tool aimed at ascertainment of functional status explicitly, and its clinical and sociodemographic correlates. Materials and methods: A total of 189 women recruited from a large, urban women's hospital in the northeastern United States who both (1) screened positive for depression between 4 and 6 weeks postpartum and (2) completed a subsequent home (baseline) visit between October 1, 2008, and September 4, 2009, were included in this analysis. Multiple linear regression was conducted to ascertain which clinical and sociodemographic variables were independently associated with maternal functioning. Results: The multivariate analysis revealed independent associations between bipolar status, atypical depression, depression score (17-item Hamilton Rating Scale for Depression), and insurance type with postpartum maternal functioning. The beta coefficient for bipolar status indicates that on average we would expect those with bipolar disorder to have maternal functioning scores that are 5.6 points less than those without bipolar disorder. Conclusions: Healthcare providers treating postpartum women with complicating mental health conditions should be cognizant of the potential ramifications on maternal functioning. Impaired functioning in the maternal role is likely to impact child development, although the precise nature of this relationship is yet to be elucidated.
    Full-text · Article · Nov 2015 · Journal of Women's Health

  • No preview · Article · Nov 2015 · Critical care medicine

  • No preview · Article · Nov 2015 · Critical care medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Although diffuse systemic sclerosis (SSc) is associated with a reduction in life expectancy, there are no validated, prognostic models for 5-year mortality in diffuse SSc. The objective of this study was to derive and validate a 5-year mortality prediction rule for early diffuse SSc patients. Methods: We used an inception cohort of 388 Caucasian US patients with early diffuse SSc (< 2 years from the first symptom). Predefined baseline variables were entered into a stepwise logistic regression model to identify factors independently associated with 5-year all-cause mortality. After rounding the beta-weights to the nearest integer, and summing them, we stratified patients into low (<0 points), moderate (1-2 points) and high-risk (≥ 3 points) groups. We then applied this rule to an external validation cohort of 110 Caucasian early diffuse SSc patients from the Royal Free Hospital cohort and compared stratum-specific 5-year mortality. Results: Six independent predictors (rounded beta-weight) comprised the model: age at first visit (-1, 0, 1), male gender (0,1), tendon friction rubs (0,1), gastrointestinal involvement (0,1), RNA polymerase III antibody (0,1) and anemia (0,1). The 3-level risk stratification model performed well with no significant differences between the US derivation (AUC =0.73 (95% CI 0.69-0.78)) and UK (AUC= 0.69 (95% CI 0.61-0.77)) validation cohorts. Conclusion: We have derived and externally validated in US and UK cohorts an easy-to-use 6-variable prediction rule that assigns low, moderate and high risk categories for 5-year mortality in early diffuse SSc patients. Only history, exam and basic labs are required. This article is protected by copyright. All rights reserved.
    No preview · Article · Nov 2015 · Arthritis and Rheumatology
  • [Show abstract] [Hide abstract]
    ABSTRACT: As serotonin reuptake inhibitor (SRI) use may decrease platelet function, previous research has shown a relationship between SRI use and an increased risk for bruising and bleeding. The literature regarding the association between SRI use during pregnancy and increased bleeding at delivery, referred to as postpartum hemorrhage (PPH), is mixed. In secondary analyses from two prospective observational studies of pregnant women with mood disorders, 263 women were exposed to an SRI (n = 51) or not (n = 212) in the third trimester. To be precise, we used the terminology estimated blood loss (EBL) >600 cc rather than the term PPH because the current definition of PPH differs. The occurrence of EBL >600 cc was determined using the Peripartum Events Scale (PES) completed from obstetrical records by a blinded medically trained member of the study team. EBL >600 cc occurred in 8.7% of women in this cohort. There was no statistically significant difference in the rates of EBL >600 cc in the 24 h after delivery in women taking SRIs during the third trimester (9.8%) compared to non-exposed women (8.5%). Utilizing generalizing estimating equations, the odds of EBL >600 cc in each group were not significantly different (OR 1.17, CI-0.41-3.32, p = 0.77). When the SRI group was limited to women with exposure at the time of delivery, the difference in the odds of EBL >600 cc was unchanged (OR 1.16, CI = 0.37-3.64, p = 0.79). In population, both third trimester and use at delivery of SRIs during pregnancy was not associated with an increased risk of excessive blood loss.
    No preview · Article · Nov 2015 · Journal of Psychiatric Research
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: The aims of this study were to assess the agreement of physicians and nurses performing tender and swollen joint counts (TJCs/SJCs) in rheumatoid arthritis (RA) and identify factors that might influence their examinations including patient age, sex, race, RA disease duration, body mass index, RA disease activity level, comorbid fibromyalgia, comorbid osteoarthritis, and levels of acute-phase reactants. Methods: Seventy-two RA participants underwent TJCs/SJCs of 28 joints using a standardized protocol by 2 nurses and 2 rheumatologists. Demographic, laboratory, radiographic, and clinical data were obtained to assess the influence of these factors on TJCs/SJCs. Intraclass correlations (ICCs) among examiners were determined for TJCs/SJCs. Nurse-physician differences and agreement of individual joints were evaluated using Cohen κ. Analysis of variance was performed to detect differences in means between examiners for TJCs/SJCs. Intraclass correlation and Fisher Z tests were used to identify factors influencing TJCs/SJCs. Results: Agreement was strong among these nurses and physicians for total TJCs/SJCs (ICC = 0.84/ICC = 0.79, respectively). κ was best for hand joint tenderness and poorest for shoulder swelling. Some significant differences in mean TJCs/SJCs were found between examiners. Fibromyalgia significantly reduced agreement of both TJCs and SJCs. Agreement of TJC was significantly reduced when patients had lower disease activity, greater work impairment, lower mental health quality of life, and elevated erythrocyte sedimentation rate, whereas female sex, assessor's perception of but not radiographic hand osteoarthritis, and elevated C-reactive protein significantly reduced agreement for SJC. Conclusions: Strong agreement was found among nurses and physicians for total 28-joint counts, with agreement at individual joints being stronger for tenderness than swelling. Fibromyalgia significantly reduced ICCs of TJCs/SJCs.
    No preview · Article · Oct 2015 · Journal of clinical rheumatology: practical reports on rheumatic & musculoskeletal diseases

  • No preview · Conference Paper · Oct 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sarcoidosis is a systemic disease characterized by noncaseating granulomatous inflammation with tremendous clinical heterogeneity and uncertain pathobiology and lacking in clinically useful biomarkers. The Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study is an observational cohort study designed to explore the role of the lung microbiome and genome in these two diseases. This article describes the design and rationale for the GRADS study sarcoidosis protocol. The study addresses the hypothesis that distinct patterns in the lung microbiome are characteristic of sarcoidosis phenotypes and are reflected in changes in systemic inflammatory responses as measured by peripheral blood changes in gene transcription. The goal is to enroll 400 participants, with a minimum of 35 in each of 9 clinical phenotype subgroups prioritized by their clinical relevance to understanding of the pathobiology and clinical heterogeneity of sarcoidosis. Participants with a confirmed diagnosis of sarcoidosis undergo a baseline visit with self-administered questionnaires, chest computed tomography, pulmonary function tests, and blood and urine testing. A research or clinical bronchoscopy with a research bronchoalveolar lavage will be performed to obtain samples for genomic and microbiome analyses. Comparisons will be made by blood genomic analysis and with clinical phenotypic variables. A 6-month follow-up visit is planned to assess each participant's clinical course. By the use of an integrative approach to the analysis of the microbiome and genome in selected clinical phenotypes, the GRADS study is powerfully positioned to inform and direct studies on the pathobiology of sarcoidosis, identify diagnostic or prognostic biomarkers, and provide novel molecular phenotypes that could lead to improved personalized approaches to therapy for sarcoidosis.
    No preview · Article · Oct 2015 · Annals of the American Thoracic Society
  • [Show abstract] [Hide abstract]
    ABSTRACT: Severe deficiency of alpha-1 antitrypsin has a highly variable clinical presentation. The GRADS Alpha-1 Study is a prospective, multicenter, cross-sectional, study of adults > age 35 with PiZZ or PiMZ alpha-1 antitrypsin genotypes designed to better understand if microbial factors influence this heterogeneity. Clinical symptoms, pulmonary function testing, computed chest tomography, exercise capacity, and bronchoalveolar lavage (BAL) will be used to define COPD phenotypes that can be studied with an integrated systems biology approach that includes plasma proteomics; mouth, BAL, and stool microbiome and virome analysis; blood miRNA, and blood mononuclear cell RNA and DNA profiling, and relies on global genome, transcriptome, proteome, and metabolome datasets. Matched cohorts of PiZZ participants on or off augmentation therapy, PiMZ participants not on augmentation therapy, and control participants from SPIROMICS who match on FEV1 and age will be compared. The primary analysis will determine if the PiZZ individuals on augmentation therapy have a difference in lower respiratory tract microbes identified compared to matched PiZZ individuals who are not on augmentation therapy. By characterizing the microbiome in alpha-1 antitrypsin deficiency (AATD), we hope to define new phenotypes of COPD that explain some of the diversity of clinical presentations. As a unique genetic cause of COPD, AATD may inform usual COPD pathogenesis and help understand the complex interplay between the environment and genetics. Although the biologic approaches are hypothesis-generating, the results may lead to development of novel biomarkers, better understanding of COPD phenotypes, and development of novel diagnostic and therapeutic trials in AATD and COPD. Clinical Trial registered with clinicaltrials.gov (NCT01832220).
    No preview · Article · Jul 2015 · Annals of the American Thoracic Society
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the effects of symptoms and presence of confirmed influenza on intention to receive an influenza vaccine, specifically in patients recovering from a medically-attended acute (≤ 7 days' duration) respiratory illness (ARI). During the 2013-14 influenza season individuals seeking outpatient care for an ARI that included cough were tested for influenza using reverse transcription polymerase chain reaction assays (PCR) and completed surveys. Children (6 months-18 years) and adults (≥ 18 years) were grouped by their combined current season's influenza vaccination status (vaccinated/not vaccinated) and their vaccination intentions for next season (intend/do not intend). Overall, 41% (323/786) were unvaccinated at enrollment; of those, nearly half (151/323) intended to be vaccinated next season. When adjusting for demographic, health, and other factors, unvaccinated individuals who intended to be vaccinated next season were approximately 1.5 times more likely to have PCR-confirmed influenza compared with vaccinated individuals who intended to be vaccinated next season. The combined experience of not being vaccinated against influenza and seeking medical attention for an ARI seemed to influence approximately one-half of unvaccinated participants to consider influenza vaccination for next season.
    No preview · Article · Jul 2015 · American journal of health behavior

  • No preview · Conference Paper · Jun 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Postpartum depression occurs in 14.5% of women in the first 3 months after birth. This study was an 8-week acute phase randomized trial with 3 cells [transdermal estradiol (E2), sertraline (SERT), and placebo (PL)] for the treatment of postpartum major depressive disorder. However, the study was stopped after batch analysis revealed that the E2 serum concentrations were lower than prestudy projections. This paper explores our experiences that will inform future investigations of therapeutic E2 use. Explanations for the low E2 concentrations were as follows: (1) study patch nonadhesion, which did not explain the low concentrations across the entire sample. (2) Ineffective transdermal patch preparations, although 2 different patch preparations were used and no significant main effect of patch type on E2 concentrations was found. (3) Obesity, at study entry, E2-treated women had body mass index of 32.9 (7.4) [mean (SD)]. No pharmacokinetic data comparing E2 concentrations from transdermal patches in obese women versus normal weight controls are available. (4) Induction of cytochrome P450 (CYP450) 3A4 and other E2 elimination pathways in pregnancy. CYP4503A4 is induced in pregnancy and is a pathway for the metabolism of E2. Conversion to estrone and phase II metabolism via glucuronidation and sulfation, which also increase in pregnancy, are routes of E2 elimination. The time required for these pathways to normalize after delivery has not been elucidated. The observation that transdermal E2 doses greater than 100 μg/d did not increase serum concentrations was unexpected. Another hypothesis consistent with this observation is suppression of endogenous E2 secretion with increasing exogenous E2 dosing.
    Full-text · Article · Jun 2015 · Journal of clinical psychopharmacology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Accurate measurement of disease activity is important for optimal management of patients with rheumatoid arthritis (RA). Better understanding of similarities and differences among the available clinical and biomarker-based disease activity measures may improve their use for therapeutic decision-making. Objectives Evaluate the relationship between available disease activity indices and their association with other clinical variables. Methods A cross-sectional analysis was performed for 734 RA patients enrolled in the University of Pittsburgh Rheumatoid Arthritis Comparative Effectiveness Registry (RACER), using all first visits and excluding patients (N=6) who were receiving tocilizumab. Spearman's rank correlation and percentage agreement among 4 disease activity categories (remission, low, moderate, high) were calculated for Disease Activity Score 28 with C-reactive protein (DAS28-CRP), Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI), Routine Assessment of Patient Index 3 (RAPID3) and the Multi-biomarker Disease Activity (MBDA) score. Univariate regression analyses were performed to assess association between each disease activity score and American College of Rheumatology (ACR) Core Data Set measures, demographics, and co-morbidities. P-values were adjusted for multiple comparisons using the Benjamini-Hochberg procedure. Results For 734 patients, mean age and disease duration were 60 and 15 years, respectively. Mean RAPID3, DAS28-CRP, SDAI, CDAI, and MBDA scores were 3.6, 3.3, 15.1, 14.1, and 41.3, respectively. Each disease activity measure was significantly correlated with the others. DAS28-CRP, CDAI, and SDAI correlated strongly with each other (r=0.92–0.99) and to a lesser degree with RAPID3 (r=0.65–0.66) and MBDA score (r=0.35–0.51). Correlation between MBDA score and RAPID3 was lowest (r=0.27). Agreement among categories between DAS28-CRP and CDAI or SDAI was 45% and 56%, respectively, and between CDAI and SDAI was 88%. Agreement between DAS28-CRP and RAPID3 or MBDA score was 47% and 44%, respectively. Agreement between RAPID3 and MBDA score was 38%. All 7 ACR Core measures were significantly associated with disease activity for each index (Figure). RAPID3 was significantly associated with all measured comorbidities and opiate use; DAS28-CRP, SDAI, and CDAI with fibromyalgia and opiate use; and MBDA score with the Deyo-Charlson comorbidity index. DAS28-CRP, SDAI, and CDAI were not significantly associated with the demographic variables. RAPID3 was significantly associated with race and BMI, and MBDA score with age and BMI. Only MBDA score was significantly associated with seropositivity and not with the Short Form Health Survey (SF12) mental composite score Conclusions Disease activity indices were significantly correlated with each other and associated with ACR core measures. However, they differed in their relationships with co-morbidities or demographics. These results suggest that disease activity may not be comprehensively assessed by any single composite measure. Disclosure of Interest Y. G. Hwang: None declared, G. Wu Shareholder of: Myriad Genetics, Inc, Employee of: Crescendo Bioscience, J. Feng: None declared, J. Lyons: None declared, H. Eng: None declared, S. Wisniewski: None declared, C. Hwang Shareholder of: Myriad Genetics, Inc, Employee of: Crescendo Bioscience, E. Sasso Shareholder of: Myriad Genetics, Inc, Employee of: Crescendo Bioscience, O. Segurado Shareholder of: Myriad Genetics, Inc, Employee of: Crescendo Bioscience, L. Moreland: None declared
    No preview · Conference Paper · Jun 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Women with bipolar disorder (BD) are at high risk for postpartum affective episodes and psychosis. Although validated screening tools are available for postpartum unipolar depression, few screening tools for hypomania/mania exist. Screening tools for BD in the postpartum period are essential for improving detection and planning appropriate treatment. We evaluated whether adding the Mood Disorders Questionnaire (MDQ) to the Edinburgh Postnatal Depression Scale (EPDS) increased the identification of BD in the early postpartum period.Methods Women (N = 1,279) who delivered a live infant and screened positive on the EPDS and/or MDQ at 4–6 weeks postbirth were invited to undergo an in-home Structured Clinical Interview for DSM-IV (SCID).ResultsPositive EPDS and/or MDQ screens occurred in 12% of the sample (n = 155). In home SCID diagnostic interviews were completed in 93 (60%) of the mothers with positive screens. BD was the primary diagnosis in 37% (n = 34). Women with BD screened positive on the EPDS and/or MDQ as follows: EPDS+/MDQ+ (n = 14), EPDS+/MDQ- (n = 17), and EPDS-/MDQ+ (n = 3). The MDQ identified 50% (17/34) of the women with BD and 6 additional cases of BD when the MDQ question regarding how impaired the mother perceived herself was excluded from the screen criterion.Conclusion Addition of the MDQ to the EPDS improved the distinction of unipolar depression from bipolar depression at the level of screening in 50% of women with traditional MDQ scoring and by nearly 70% when the MDQ was scored without the impairment criterion.
    Full-text · Article · Jun 2015 · Depression and Anxiety
  • [Show abstract] [Hide abstract]
    ABSTRACT: Conclusive evidence is lacking regarding the benefits and risks of performing off-pump versus on-pump coronary artery bypass graft (CABG) for patients with diabetes. This study aims to compare clinical outcomes after off-pump and on-pump procedures for patients with diabetes. The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial enrolled patients with type 2 diabetes and documented coronary artery disease, 615 of whom underwent CABG during the trial. The procedural complications, 30-day outcomes, long-term clinical and functional outcomes were compared between the off-pump and on-pump groups overall and within a subset of patients matched on propensity score. On-pump CABG was performed in 444 (72%) patients, and off-pump CABG in 171 (28%). The unadjusted 30-day rate of death/myocardial infarction (MI)/stroke was significantly higher after off-pump CABG (7.0 vs 2.9%, P = 0.02) despite fewer complications (10.3 vs 20.7%, P = 0.003). The long-term risk of death [adjusted hazard ratio (aHR): 1.41, P = 0.2197] and major cardiovascular events (death, MI or stroke) (aHR: 1.47, P = 0.1061) did not differ statistically between the off-pump and on-pump patients. Within the propensity-matched sample (153 pairs), patients who underwent off-pump CABG had a higher risk of the composite outcome of death, MI or stroke (aHR: 1.83, P = 0.046); the rates of procedural complications and death did not differ significantly, and there were no significant differences in the functional outcomes. Patients with diabetes had greater risk of major cardiovascular events long-term after off-pump CABG than after on-pump CABG. © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
    No preview · Article · May 2015 · European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Suicide is one of the leading causes of death in postpartum women. Identifying modifiable factors related to suicide risk in mothers after delivery is a public health priority. Our study aim was to examine associations between suicidal ideation (SI) and plausible risk factors (experience of abuse in childhood or as an adult, sleep disturbance, and anxiety symptoms) in depressed postpartum women. This secondary analysis included 628 depressed mothers at 4-6 weeks postpartum. Diagnosis was confirmed with the Structured Clinical Interview for DSM-IV. We examined SI from responses to the Edinburgh Postnatal Depression Scale-EPDS item 10; depression levels on the Structured Interview Guide for the Hamilton Depression Rating Scale, Atypical Depression Symptoms (SIGH-ADS); plus sleep disturbance and anxiety levels with subscales from the EPDS and SIGH-ADS items on sleep and anxiety symptoms. Of the depressed mothers, 496 (79%) 'never' had thoughts of self-harm; 98 (15.6%) 'hardly ever'; and 34 (5.4%) 'sometimes' or 'quite often'. Logistic regression models indicated that having frequent thoughts of self-harm was related to childhood physical abuse (odds ratio-OR = 1.68, 95% CI = 1.00, 2.81); in mothers without childhood physical abuse, having frequent self-harm thoughts was related to sleep disturbance (OR = 1.15, 95% CI = 1.02, 1.29) and anxiety symptoms (OR = 1.11, 95% CI = 1.01, 1.23). Because women with postpartum depression can present with frequent thoughts of self-harm and a high level of clinical complexity, conducting a detailed safety assessment, that includes evaluation of childhood abuse history and current symptoms of sleep disturbance and anxiety, is a key component in the management of depressed mothers. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Full-text · Article · May 2015 · Journal of Psychiatric Research

  • No preview · Article · Apr 2015 · Annals of internal medicine

Publication Stats

24k Citations
2,416.24 Total Impact Points

Institutions

  • 1996-2015
    • University of Pittsburgh
      • • Graduate School of Public Health
      • • Department of Epidemiology
      • • Safar Center for Resuscitation Research
      • • Department of Pediatrics
      • • Department of Pediatric Neurosurgery
      Pittsburgh, Pennsylvania, United States
  • 2013
    • Childrens Hospital of Pittsburgh
      Pittsburgh, Pennsylvania, United States
    • VA Palo Alto Health Care System
      Palo Alto, California, United States
    • UPMC
      Pittsburgh, Pennsylvania, United States
    • Portland State University
      Portland, Oregon, United States
  • 2011
    • University of California, San Diego
      • Department of Psychiatry
      San Diego, California, United States
  • 2005-2011
    • Columbia University
      • Department of Psychiatry
      New York, New York, United States
    • Massachusetts General Hospital
      • Department of Psychiatry
      Boston, MA, United States
    • Harvard Medical School
      • Department of Psychiatry
      Boston, MA, United States
  • 2008-2010
    • University of Texas Southwestern Medical Center
      • Department of Psychiatry
      Dallas, TX, United States
    • Northwestern University
      • Asher Center – Study & Treatment of Mood Disorders
      Evanston, Illinois, United States
    • University of Texas at Dallas
      • School of Behavioral and Brain Sciences
      Richardson, Texas, United States
    • Karolinska Institutet
      • Department of Neuroscience
      Solna, Stockholm, Sweden
  • 2007
    • University of Colorado at Boulder
      Boulder, Colorado, United States
  • 2006-2007
    • Boston University
      • Department of Psychology
      Boston, Massachusetts, United States
    • Harvard University
      Cambridge, Massachusetts, United States
    • Via Christi Health
      Wichita, Kansas, United States
    • Brown University
      • Department of Psychiatry and Human Behavior
      Providence, RI, United States
    • New York State Psychiatric Institute
      • Anxiety Disorders Clinic
      New York, New York, United States
  • 1998-2006
    • Western Psychiatric Institute and Clinic
      Pittsburgh, Pennsylvania, United States
  • 2004
    • University of Colorado
      • Department of Psychiatry
      Denver, Colorado, United States